KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Shenzhen Daily, China - 27 July 2012
Shenzhen is among 10 provinces and cities that will implement a value-added tax pilot program between Aug 1 and the end of the year, meaning some businesses will see tax cuts... Read the full article
Related links
RSS feeds